The following resources are available for the Provincial Opioid Addiction Treatment Support Program.
PHYSICIANS AND NURSE PRACTITIONERS’ EDUCATION AND TRAINING PATHWAY
Workbooks (physicians and nurse practitioners)
- Community Settings (updated May 2025)
- Acute Care Settings (updated May 2025)
- iOAT (email [email protected] for access)
Preceptorship (physicians and nurse practitioners)
- The Preceptorship Contact List is available within the POATSP course on the UBC CPD learning platform. Once all course requirements have been successfully completed, the Preceptorship Contact List will become available in the Resources section
POATSP Online Course
REGISTERED NURSE AND REGISTERED PSYCHIATRIC NURSE OPIOID USE DISORDER CERTIFIED EDUCATION AND TRAINING PATHWAY
Certified Practice Competencies
POATSP: Registered Nurses and Registered Psychiatric Nurses online course
Workbook
- Email [email protected] for the RN/RPN workbook
Preceptorship
- Once a Certificate of Completion is provided from POATSP: RNs and RPNs, the BCCSU will provide information to schedule a preceptorship
Decision Support Tools
- Decision Support Tool for RN and RPN Prescribing of Buprenorphine
- The Sublocade product monograph was updated by Health Canada in December 2025, to reflect the addition of on-label prescribing of alternative injection sites and a rapid induction. Please consult the Extended-release Buprenorphine Bulletin for updated information. While CP-OUD DST revisions are in progress to determine CP-OUD RN/RPN clinical decision-making points in relation to these updates, CP-OUD RNs/RPNs are required to refer to an MD/NP if a patient is interested in alternative injection sites and/or rapid induction
- Decision Support Tool for RN and RPN Prescribing of Methadone or Slow-release Oral Morphine
Prescribing
- BCCNM Prescribing standards for registered nurses or registered psychiatric nurses
Resources for all prescribers
Support Line
- 24/7 Addiction Medicine Clinician Support Line: 778-945-7619
Clinical guidance
- For the latest guidance for opioid use disorder, visit the opioid use disorder care guidance page
- For guidance designed to support clinicians as they begin practicing as new OAT prescribers, view the OAT Prescriber Resource Guide
Screening and diagnosis
Medication-specific resources
Buprenorphine/naloxone
- Buprenorphine/naloxone Common Drug–Drug Interactions
- Clinical Opiate Withdrawal Scale (COWS)
- Subjective Opiate Withdrawal Scale (SOWS)
- Traditional Buprenorphine/naloxone Induction: Medications to Minimize Withdrawal Symptoms
- Buprenorphine/naloxone (Suboxone) To Go: Traditional Induction
- Buprenorphine/naloxone (Suboxone) To Go: Low-dose Induction (micro-dosing)
- Buprenorphine/naloxone (Suboxone) To Go: Low-dose Induction (micro-dosing) Wallet-size Dosing Schedule
Methadone
Slow-release oral morphine
All OAT
- Opioid Agonist Treatment Clinics Accepting New Patients
- Opioid Agonist Treatment Pharmacies
- Detection Time of Substances in Urine
British Columbia Substance Use Disorder Community of Practice Inventory